TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Feb 14, 2017
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2017-02-13+80,000→ 80,000 totalExercise: $3.90Exp: 2027-02-13→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The options vest in 24 equal monthly installments commencing on the grant date.